CClinicalTrials.gg
Not yet recruitingNCT07315464MWMUpdated Jan 2, 2026

Effects of MWM Vs Sustained Mobilization on Knee Osteoarthritis

An interventional study of mulligan moblization and kaltenborn moblization in Knee Osteoarthritis, sponsored by Lahore University of Biological and Applied Sciences. Not yet recruiting at 1 site in Pakistan. Open to participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-01-02.

Sponsored by Lahore University of Biological and Applied Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
45 Years to 70 Years
Sex
All
01

Study summary

This article focused on people diagnosed with grade III Knee OA with sample size of 68 patients , who will randomly divided into two groups . Group A received Mulligan's MWM while group B received Kaltenborn's Sustained Mobilization along with eccentric exercises. The goal of the study was to compare the effectiveness of these two treatment conditions in reducing knee pain and improving joint function decreasing disability in daily activities. The patients followed a structured treatment plan over a set period and outcomes will measured using reliable clinical tools such as NPRS for pain KOOS for functional disability and Goniometer for ROM.

Read the detailed description

The word osteoarthritis (OA) is comprised of two separate terms: the prefix "osteo" means bone, and arthritis means joint inflammation. Subcommittee on Osteoarthritis of the American Rheumatism Association, Diagnostic and Therapeutic Criteria Committee, defined OA as "a heterogeneous group of conditions that lead to joint symptoms and signs which are associated with defective integrity of articular cartilage, in addition to related changes in the underlying bone and at the joint margins. "The prevalence of knee pain and symptomatic OA is double in female as compared to male over 20 years. According to a study in people of age 45 or above prevalence of OA is 20% in women and 10% in men. The causes of knee OA include factors such as age, gender, weight, genetics, injuries, and overuse. Common signs and symptoms of knee OA include knee pain, joint stiffness, decreased muscle strength, and proprioceptive deficits. In addition, individuals with knee OA often exhibit poor neuromuscular control, slower walking speed, decreased functional ability, and an increased susceptibility to falling.The most common scale for knee OA classification is the Kellgren-Lawrence (KL) system, which evaluates osteophyte formation, articular cartilage narrowing associated with subchondral bone sclerosis, and altered shape of bone ends from grade 0 to grade 4.

KL classification:

Grade 0: no narrowing; Grade 1: doubtful articular space constriction, osteophytic lipping is possible; Grade 2: permanent osteophytes, potential constriction of the joint space; Grade 3: mild osteophytes, definite constriction of the joint space, and potential end-bone deformation; Grade 4: severe osteophytes, severe constriction of the joint space, severe sclerosis, and definite deformation of the bone.

Radiographes or X-rays to assess pain and restlessness are the foundation for detecting and diagnosing knee OA. Key features that can be observed using X-rays are joint space narrowing, osteophytes, cyst formation, and subchondral sclerosis.The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a wellknown useful diagnostic tool to assess knee ligament injury and osteoarthritis. It includes 42 items in five sub-scales evaluating pain, symptoms, function of daily living, sport and recreation function (sport/rec), and (QOL).The Management of knee OA needs a multidisciplinary approach. The conservative treatment forms for knee OA comprise pharmacological and non-pharmacological modalities. Non-steroidal anti-inflammatory drugs (NSAIDS) are mostly used for pain relief and stiffness caused by OA, with the numerous side effects, particularly on the gastrointestinal tract, making the treatment unsustainable.Manual therapy is a technique used to treat musculoskeletal dysfunctions and pain and usually includes manual therapies, such as massages, joint mobilization, and manipulations. Among the mobilization techniques, Mulligan's mobilization with movement (MWM) has been considered a good alternative for the treatment of musculoskeletal disorders, improving pain and ROM.MWM is based on the concept that minor position faults occur in articulating surfaces of joints following injury or strains, resulting in movement restriction and pain exacerbated by active contraction of muscles within the faulty positions of the joint. Thus, MWM involves passive accessory glide as a corrective technique, applied by the therapist perpendicular to the joint plane to correct the positional fault, combined with the offending movement being performed actively by the subject and sustained for several repetitions. The pain should always be reduced and/or eliminated during the application, and pain-free function should be restored.Sustained mobilisation is a hands-on therapy technique often used in the treatment of knee OA to help reduce pain and improve how well the joint moves. It involves gently holding the joint in a stretched or distracted position for a period of time, which can help loosen stiff tissues, improve joint lubrication, and ease discomfort. For people with knee osteoarthritis-who often experience pain, stiffness, and limited mobility-this type of mobilisation can be a useful way to manage symptoms and support better function. When combined with exercises and other rehabilitation strategies, sustained mobilisation may play a valuable role in improving overall joint health and quality of life.Eccentric exercise actions are characterized by low energy cost, high force production, hypertrophic impact, and a favorable effect on fall risk, physical function, and mobility. Eccentric resistance training may also increase volitional drive and reduce corticospinal inhibition to the muscle more than concentric training in OA. Eccentric actions are essential in daily activities, such as stair descent, squatting, or sitting into a chair.Therefore, this study aims to directly compare MWM and sustained mobilization, each integrated with eccentric strengthening exercises, to determine which approach is more effective for improving pain, range of motion, and functional performance in patients with Grade 3 knee OA. The findings will support physiotherapists in selecting the most appropriate, evidence-based interventions to enhance quality of life and functional independence for individuals living with moderate knee osteoarthritis.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Knee Osteoarthritis
  • Mobilization with Movement (MWM)
  • Sustained Mobilization
  • Eccentric Exercises
  • Kellgren-Lawrence (KL) system
  • Numeric Pain Rating Scale (NPRS)
  • Knee Injury and Osteoarthritis Outcome Score (KOOS)
03

In context

Osteoarthritis, Knee

3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.

This study's planned enrollment of 68 is close to the median of 70 across 2,731 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Lahore University of Biological and Applied Sciences is the lead sponsor of 75 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Age between 45 and 70 years Both male and female patients with a history of knee osteoarthritis were selectedfor this study. Clinically and radiologically diagnosed with Grade III Knee Osteoarthritis (basedon Kellgren and Lawrence scale).

Meets ACR criteria for knee OA

Exclusion criteria

Exclusion Criteria:

History of knee or lower limb surgery Received corticosteroid injections (oral or intra-articular) in the past 6 months Other musculoskeletal conditions in the lower limb(e.g., fracture, bursitis, back pain with radiating symptoms) Diagnosed with inflammatory joint diseases (e.g., rheumatoid arthritis, gout) Neurological conditions affecting lower limbs (e.g., stroke, neuropathy) BMI > 35 (severe obesity) that limits safe participation in exercises Any contraindications to manual therapy (e.g., malignancy, infection, unstablejoint)

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Mulligan Mobilization

    This group will hold intervention for MWM including passive glides while the eccentric exercises includes slow controlled squats

    Other: mulligan moblization

  • Active comparator
    Kaltenborn Mobilization

    This arm's intervention includes grade II traction and eccentric loading

    Other: kaltenborn moblization

Interventions

  • Othermulligan moblization

    This group will receive total 3 sessions / week (9-12 sessions) Intensity includes Accessory Glide with pain free active knee motion + moderate intensity eccentric loading Type includes Mulligan MWM ( Passive Glide during active knee flexion/extension + Eccentric Quadricpes Exercises (Slow Controlled Squats ) Time 30-45 mins

    Also known as: slow controlled squats

  • Otherkaltenborn moblization

    This group will receive frequency of 3 session/ week (9-12 sessions) Intensity includes Kaltenborn Grade II Traction according to pain tolerance + Moderate Intensity Eccentric Loading Type of Exercise includes Sustained Joint Mobilization in loose pack position + Quadriceps Exercises (Slow step down ) Time 35-45 mins

    Also known as: Eccentric Loading

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    The tool used for accessing pain is NPRS. The Numeric Pain Rating Scale (NPRS) is a widely used subjective measure for assessing pain intensity, where participants rate pain on a scale from 0 to 10. A score of 0 indicates no pain, while 10 represents the worst pain imaginable. The NPRS is simple, quick to administer, and highly useful for tracking changes in pain levels over time, evaluating treatment effectiveness, and guiding clinical decision-making. Its reliability and ease of use make it a standard tool in both clinical practice and research settings. Both MWM and Sustained Mobilization aim to reduce pain. The time frame for assessing pain is 4 weeks . While investigator aim to measure at baseline , week 2 and week 4 .

    Time frame: 4 weeks

  2. Functional Disability

    The tool used for accessing functional disability is KOOS. The KOOS is a comprehensive, patient-reported outcome measure used to evaluate symptoms, functional limitations, and quality of life in individuals with knee injuries or knee osteoarthritis. It includes five subscales: Pain, Symptoms, Activities of Daily Living (ADL), Sport and Recreation Function, and Knee-related Quality of Life. Each item is scored on a 5-point Likert scale and then converted to a 0-100 scale, where 0 represents extreme knee problems and 100 indicates no knee problems. Each subscale is scored independently, allowing clinicians and researchers to assess specific domains of knee function and monitor changes over time. The KOOS is valued for its sensitivity to both short-term and long-term functional outcomes. While invesyigator aim to measure at baseline , week 2 and week 4 .

    Time frame: 4 weeks

Secondary outcomes

  1. ROM

    The tool used for accessing ROM is Goniometer. A goniometer is a standard clinical tool used to measure the range of motion (ROM) in patients with knee osteoarthritis. It provides an objective assessment of joint mobility by measuring angles during knee flexion and extension. The stationary arm is aligned with the femur, the movable arm with the tibia, and the axis is positioned over the lateral epicondyle of the femur. ROM values help identify functional limitations, monitor disease progression, and evaluate the effectiveness of therapeutic interventions. Accurate goniometric measurement is essential for documenting baseline impairments and tracking improvements throughout rehabilitation.The time frame for assessing pain is 4 weeks . While investigator aim to measure at baseline , week 2 and week 4 .

    Time frame: 4 weeks

07

Study locations

1 site
  • Mayo hospital, Ghurki Trust Teaching Hospital
    Lahore, Punjab Province 54600, Pakistan
08

References and documents

Publications

  • Vincent KR, Vincent HK. Concentric and Eccentric Resistance Training Comparison on Physical Function and Functional Pain Outcomes in Knee Osteoarthritis: A Randomized Controlled Trial. Am J Phys Med Rehabil. 2020 Oct;99(10):932-940. doi: 10.1097/PHM.0000000000001450. PubMed 32324615 ↗
  • Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med. 2011 Spring;2(2):205-12. PubMed 24024017 ↗
  • Kataria Sweta Shah, K., Effect of Kaltenborn Traction versus Mulligan Mobilization with Movement as an adjunct to Conventional Exercise on Pain and Functions in Knee Osteoarthritis. International Journal of Science and Research (IJSR), 2023. 12(3): p. 1178-1182.
  • Gul, H. and I. Tahir, EFFECTS OF MULLIGAN ROTATIONAL MOVEMENT VERSUS MEDIAL GAPPING TECHNIQUE ON PAIN, RANGE OF MOTION AND DISABILITY IN PATIENTS WITH KNEE OSTEOARTHRITIS. Pakistan Journal of Rehabilitation, 2024. 13(1): p. 99-110.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07315464
Lead sponsor
Lahore University of Biological and Applied Sciences
Responsible party
Sponsor
First posted
Jan 2, 2026
Start date
Dec 30, 2025 (estimated)
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Jan 2, 2026

Study contacts

Fakiha Nayab, DPT
Contact
fakihamughal90@gmail.com
03245399916
Wafa Mansha, MS NMPT
Contact
wafamalik583@gmail.com
03266303005

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion